Nu Skin Enterprises, Inc. cash flow to debt ratio of 22.04% indicates that the company cannot generate enough cash to cover its debt over time. This level indicates weak financial health.

Nu Skin Enterprises, Inc.'s free cash flow has decreased -34.42% from $70.16M last year to $46.01M, signaling decreasing performance

Nu Skin Enterprises, Inc.'s debt to equity ratio is 0.35, which means that the company's assets are healthy financed, signaling financial stability. READ MORE: A ratio under 0.60 means the company finances its assets with own equity, signaling financial stability and good management.

Nu Skin Enterprises, Inc.'s debt has decreased relative to shareholder equity from 0.73 last year to 0.35 today, signaling strengthened financials

Nu Skin Enterprises, Inc. has a net debt to EBITDA ratio of 0.48x, which is below the 3.00x threshold, indicating healthy leverage and financial stability

Nu Skin Enterprises, Inc.'s interest coverage ratio of 5.47 indicates that earnings with good margin can cover interest payments on company debt

Nu Skin Enterprises, Inc.'s profit margin has increased (-144.70%) in the last year from -8.46% to 3.78%, signaling increasing performance

Nu Skin Enterprises, Inc.'s short-term assets of $547.70M exceed its short-term liabilities of $263.73M

Nu Skin Enterprises, Inc.'s return on assets of 3.96% is lower than the 5.00% threshold, indicating inefficient asset utilization

Nu Skin Enterprises, Inc.'s return on equity of 6.84%, is lower than 15.00%, indicating bad performance

Nu Skin Enterprises, Inc.'s operating cash flow is lower than its net income, indicating that earnings may not be fully backed by cash generation

Nu Skin Enterprises, Inc. had positive net income in 4.00 out of 5 years, indicating stable and consistent earnings

Nu Skin Enterprises, Inc. has positive free cash flow, indicating the company generates cash after capital expenditures

Nu Skin Enterprises, Inc. has a free cash flow yield of 18.05%, which is above the 2.00% threshold, indicating strong cash generation relative to market value

Nu Skin Enterprises, Inc.'s yearly earnings has increased -209.28% since last year from $-146.59M to $160.20M, signaling increasing performance

Nu Skin Enterprises, Inc.'s yearly revenue has decreased -14.26% since last year from $1.73G to $1.49G, signaling decreasing performance

ROIC 6.08% (Source: FMP key-metrics). In the 5–10% partial-credit band. Score: 1 of 2. This band sits within the typical US weighted-average cost of capital range. Methodology choice can change the conclusion: under FMP's invested-capital definition the company is at or near its cost of capital; under narrower operating-capital definitions the same company may score higher. Invested capital here includes equity, non-current liabilities, and short-term debt. Cash is not subtracted. See methodology.

Nu Skin Enterprises, Inc.'s 3-year revenue CAGR of -12.61% is negative, indicating declining revenue over the past 3 years

Nu Skin Enterprises, Inc. had revenue growth in only 1.00 out of 5 years, indicating inconsistent revenue performance

Nu Skin Enterprises, Inc. had positive ROE in 4.00 out of 5 years, indicating consistent and reliable returns on equity

Nu Skin Enterprises, Inc. has insufficient data to evaluate this check.

Nu Skin Enterprises, Inc. has an earnings yield of 21.42%, which is above the 4.00% threshold, indicating the stock offers reasonable value relative to its earnings

Nu Skin Enterprises, Inc. is undervalued relative to its fair value price of 18.21 based on EBITDA multiple model

Nu Skin Enterprises, Inc. has an EV/EBITDA ratio of 2.58x, which is below the 20.00x threshold, indicating reasonable valuation relative to its operating earnings

Nu Skin Enterprises, Inc. is undervalued relative to its fair value price of 7.90 based on Earnings Fair Value model

Nu Skin Enterprises, Inc. has a PEG-ratio under 1 which is considered undervalued

Nu Skin Enterprises, Inc. has a price-to-book ratio of 0.32x, which is below the 5.00x threshold, indicating reasonable valuation relative to its book value

Nu Skin Enterprises, Inc. has a price-to-sales ratio of 0.18x, which is below the 8.00x threshold, indicating reasonable valuation relative to its revenue